1) human embryo liver cell line
人胚肝L-02细胞
2) human liver cell L-02
人胚肝细胞L-02
1.
AIM: To detect the inhibition effect of nitidine chloride on proliferation of human liver cell L-02 and human kidney cell 293 and the protective effect of acidic fibroblast growth factor(aFGF) on human liver cell L-02 and human kidney cell 293 damaged by nitidine chloride in vitro.
目的:观察氯化两面针碱在体外对人胚肝细胞L-02,人胚肾细胞293的毒性作用,及酸性成纤维细胞生长因子(aF-GF)对氯化两面针碱引起的肝、肾细胞损伤的保护作用。
3) human liver cells L-02
人肝细胞L-02
1.
Antagonistic effect of scutellarin on toxicity of selenium in human liver cells L-02;
灯盏乙素拮抗硒对人肝细胞L-02毒性的研究
4) Human L-02 hepatocyte
人肝L-02细胞
1.
Object: investigate the formation of lipid droplets and expression ofcholesterol rate-limiting enzyme—HMG-CoA reductase and transported protein— caveolin-l,detect the amount of cholesterol on human L-02 hepatocyte under the control of curcumin, to find out the effects of curcumin on cholesterol synthesis and transport.
方法:取正常人肝L-02细胞,和经50%胎牛血清造模24小时建立的脂变肝细胞模型,共同作为研究对象。
2.
Objective To investigate the possible mechanisms of curcumin increasing cholesterol transport in the fatty changed human L-02 hepatocyte.
方法取正常人肝L-02细胞作为研究对象。
5) human hepatocyte cell
人肝细胞(L-02)
1.
Objective To study the relativity of multidrug resistance gene 1(MDR1) gene expression and acquired tolerance to arsenic in human hepatocyte cell line(L-02).
目的观察多药耐药基因1(MDR1)在耐砷的人肝细胞(L-02)中的表达情况,探讨其与L-02耐砷性的关系。
2.
Methods Human hepatocyte cell line(L-02) were exposed to low-level arsenite for 6 weeks,3-[4,5-dimethy Ithiazol-2-yl]-2,5-diphenyl tetrzolium(MTT) was used to detect the survival rate and LC50 of arsenic-exposed cells and the control which can reflect the change of arsenic tolerance.
目的探讨多药耐药相关蛋白1(MRP1)与人肝细胞(L-02)耐砷性之间的关系。
6) hepatic L-02 cell
人胚胎正常肝细胞株L-02
补充资料:肝复肽 ,肝细胞水解物
药物名称:肝复肽
英文名:Hepatocyte Hydrolysate
别名: 肝复肽 ,肝细胞水解物
外文名:hepatocyte hydrohysate
适应症: 重症肝炎、急性肝炎、慢性肝炎、肝硬化的辅助治疗。
用量用法: 肌肉注射:20 mg bid,一个月为一疗程。静脉注射:40-80mg qd,一个月为一疗程。
规格: 粉剂 20 mg x 5支。
类别:肝胆疾病辅助用药
英文名:Hepatocyte Hydrolysate
别名: 肝复肽 ,肝细胞水解物
外文名:hepatocyte hydrohysate
适应症: 重症肝炎、急性肝炎、慢性肝炎、肝硬化的辅助治疗。
用量用法: 肌肉注射:20 mg bid,一个月为一疗程。静脉注射:40-80mg qd,一个月为一疗程。
规格: 粉剂 20 mg x 5支。
类别:肝胆疾病辅助用药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条